2m 2m 2m 2m 2m 2m 2m
Acadia Pharma (ACAD)
NASDAQ
$22.45+$0.36 (+1.63%)
Price as of Jun 23, 2026 11:41 AM EDT- $3.8BMarket Cap
- -1.73%1-Year Change
- BiotechnologyIndustry
Acadia Pharma (ACAD)
$22.45+$0.36 (+1.63%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.1B +11.87% | 957.8M +31.85% | 726.4M +40.45% | 517.2M +6.83% | |
Cost of Revenue | 89.0M +8.75% | 81.8M +96.55% | 41.6M +309.58% | 10.2M -6.24% | |
Gross Profit | 982.5M +12.16% | 876.0M +27.91% | 684.8M +35.05% | 507.1M +7.13% | |
Sales and Marketing Expense | 548.9M +12.38% | 488.4M +20.14% | 406.6M +10.15% | 369.1M -6.80% | |
Research and Development Expense | -328.8M +8.43% | -303.2M -13.76% | -351.6M -2.75% | -361.6M +51.02% | |
Depreciation and Amortization Expense | 10.9M -27.23% | 15.0M +265.58% | 4.1M N/A | 0 -100.00% | |
Total Operating Expenses | 966.7M +32.97% | 727.0M -9.10% | 799.8M +7.96% | 740.8M +13.18% | |
Operating Profit | 104.8M -54.59% | 230.8M +414.52% | -73.4M -67.18% | -223.6M +31.19% | |
Interest Income | 0 N/A | 0 -100.00% | 5.1M +44.24% | 3.5M +52.08% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 -100.00% | 5.1M +44.24% | 3.5M +52.08% | |
Total Nonoperating Income and Expense | 2.4M +30.06% | 1.8M -64.32% | 5.1M +44.24% | 3.5M +252.08% | |
Income before Taxes | 138.9M -46.18% | 258.1M +605.67% | -51.0M -76.09% | -213.4M +27.41% | |
Income Taxes | -252.1M -897.17% | 31.6M +208.53% | 10.3M +304.98% | 2.5M +621.08% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 391.0M +72.66% | 226.5M +469.50% | -61.3M -71.62% | -216.0M +28.66% | |
Net Income from Continuing Operations Applicable to Common | 138.9M -46.18% | 258.1M +605.67% | -51.0M -76.09% | -213.4M +27.41% | |
Basic EPS and Net Income | 2.32 +69.34% | 1.37 +470.27% | -0.37 -72.39% | -1.34 +27.62% | |
Diluted EPS and Net Income | 2.30 +69.12% | 1.36 +467.57% | -0.37 -72.39% | -1.34 +27.62% | |
Basic Weighted Average Shares | 168.4M +1.59% | 165.7M +101,058.60% | 163,819 +1.32% | 161,683 -99.90% | |
Diluted Weighted Average Shares | 169.9M +2.14% | 166.4M +101,452.32% | 163,819 +1.32% | 161,683 -99.90% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 177.7M -44.40% | 319.6M +69.40% | 188.7M +64.27% | 114.8M -22.10% | |
Short-Term Investments | 642.0M +47.11% | 436.4M +74.42% | 250.2M -17.14% | 302.0M -19.10% | |
Cash and Cash Equivalents and Short-Term Investments | 819.7M +8.43% | 756.0M +72.26% | 438.9M +5.29% | 416.8M -19.95% | |
Total Current Assets | 1.1B +13.19% | 938.3M +52.29% | 616.1M +21.30% | 507.9M -17.79% | |
Accumulated Depreciation | 9.5M -7.17% | 10.2M +6.92% | 9.6M +18.02% | 8.1M +30.93% | |
Property and Plant and Equipment and Net | 7.5M +78.20% | 4.2M -8.61% | 4.6M -23.40% | 6.0M -25.18% | |
Total Long-Term Assets | 3.9M +985.24% | 359,000 -24.58% | 476,000 -93.73% | 7.6M +89.82% | |
Total Assets | 1.6B +31.69% | 1.2B +58.59% | 749.0M +27.41% | 587.8M -16.04% | |
Income Taxes Payable | 11.2M -2.28% | 11.4M -7.83% | 12.4M -6.34% | 13.2M -5.92% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 277.1M -29.82% | 394.9M +55.31% | 254.3M +102.38% | 125.6M +30.77% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 19.1M +5.99% | 18.1M +19.21% | 15.1M +66.93% | 9.1M +29.00% | |
Total Liabilities | 336.8M -25.97% | 455.0M +43.43% | 317.2M +69.27% | 187.4M +17.69% | |
Retained Earnings | -1.8B -17.74% | -2.2B -9.32% | -2.4B +2.59% | -2.4B +10.03% | |
Total Stockholders Equity | 1.2B +67.49% | 732.8M +69.72% | 431.8M +7.83% | 400.4M -25.97% | |
Total Shares Outstanding | 170.3M +2.16% | 166.7M +1.25% | 164.7M +1.60% | 162.1M +0.65% | |
Cash Flow | |||||
Cash from Operating Activities | 109.8M -30.36% | 157.7M +844.31% | 16.7M +114.65% | -114.0M -9.25% | |
Capital Expenditures | 4.7M +796.75% | 523,000 +946.00% | 50,000 N/A | 0 -100.00% | |
Cash from Investing Activities | -302.6M +890.78% | -30.5M -195.44% | 32.0M -56.31% | 73.2M +203.01% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 49.9M +628.75% | 6.8M -72.76% | 25.1M +206.49% | 8.2M -54.86% | |
Financials Ratio | |||||
Gross Margin | 91.69% +0.26% | 91.46% -2.98% | 94.27% -3.84% | 98.03% +0.28% | |
Operating Margin | 9.78% -59.41% | 24.10% +338.55% | -10.10% -76.63% | -43.23% +22.80% | |
Return on Assets | 28.42% +21.51% | 23.39% +355.04% | -9.17% -72.66% | -33.54% +48.12% | |
Return on Equity | 39.89% +2.58% | 38.89% +364.04% | -14.73% -67.90% | -45.89% +59.63% | |
Revenue Growth | 11.87% -62.72% | 31.85% -21.26% | 40.45% +491.78% | 6.83% -28.77% | |
Current Ratio | 3.83 +61.29% | 2.38 -1.94% | 2.42 -40.06% | 4.04 -37.13% | |
Cash Ratio | 0.64 -20.78% | 0.81 +9.08% | 0.74 -18.84% | 0.91 -40.43% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow